Clinical Trial Update: Socket Augmentation Using Atorvastatin With Or Without PRGF (Clinical and Histomorphometric Study) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating socket augmentation using atorvastatin with or without PRGF for socket preservation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Socket Preservation

Drugs mentioned

• PRGF (platelet-rich growth factor)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Ain Shams University | Conditions: Socket Preservation | Phase 4 | Status: COMPLETED